BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8554227)

  • 21. Hyperkalemia with high-dose trimethoprim-sulfamethoxazole therapy.
    Greenberg S; Reiser IW; Chou SY
    Am J Kidney Dis; 1993 Oct; 22(4):603-6. PubMed ID: 8213804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Life threatening hyperkalemia and acidosis secondary to trimethoprim-sulfamethoxazole treatment.
    Margassery S; Bastani B
    J Nephrol; 2001; 14(5):410-4. PubMed ID: 11730276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimethoprim-sulfamethoxazole and the risk of a hospital encounter with hyperkalemia: a matched population-based cohort study.
    Hwang YJ; Muanda FT; McArthur E; Weir MA; Sontrop JM; Lam NN; Garg AX
    Nephrol Dial Transplant; 2023 May; 38(6):1459-1468. PubMed ID: 36208171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients.
    Plantaz MMEA; Veldman BAJ; Esselink AC; Fleuren HWHA; Kramers C
    Int J Clin Pharm; 2020 Jun; 42(3):965-971. PubMed ID: 32390087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study.
    Rajput J; Moore LSP; Mughal N; Hughes S
    Clin Microbiol Infect; 2020 Dec; 26(12):1651-1657. PubMed ID: 32220637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe hyperkalemia with trimethoprim-quinapril.
    Thomas RJ
    Ann Pharmacother; 1996 Apr; 30(4):413-4. PubMed ID: 8729901
    [No Abstract]   [Full Text] [Related]  

  • 27. Sulfamethoxazole-Trimethoprim-Induced Hyperkalemia in Hospitalized Patients Using Potassium-Sparing Drugs: An Observational Study.
    Butterhoff MH; Derijks HJ; Hermens W; van der Linden PD
    Sr Care Pharm; 2024 Jul; 39(7):259-266. PubMed ID: 38937893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperkalemia and trimethoprim-sulfamethoxazole: a new problem emerges 25 years later.
    Perazella MA
    Conn Med; 1997 Aug; 61(8):451-8. PubMed ID: 9309892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study.
    Crellin E; Mansfield KE; Leyrat C; Nitsch D; Douglas IJ; Root A; Williamson E; Smeeth L; Tomlinson LA
    BMJ; 2018 Feb; 360():k341. PubMed ID: 29438980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure.
    Tsapepas D; Chiles M; Babayev R; Rao MK; Jaitly M; Salerno D; Mohan S
    Am J Med; 2016 Dec; 129(12):1322-1328. PubMed ID: 27542610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report: reversible hyperkalemia associated with trimethoprim- sulfamethoxazole.
    Marinella MA
    Am J Med Sci; 1995 Sep; 310(3):115-7. PubMed ID: 7668307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
    Antoniou T; Gomes T; Juurlink DN; Loutfy MR; Glazier RH; Mamdani MM
    Arch Intern Med; 2010 Jun; 170(12):1045-9. PubMed ID: 20585070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of co-trimoxazole on serum potassium concentration: safety evaluation of a randomized controlled trial.
    Chan WY; Clark AB; Wilson AM; Loke YK;
    Br J Clin Pharmacol; 2017 Aug; 83(8):1808-1814. PubMed ID: 28192629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.
    Weir MA; Juurlink DN; Gomes T; Mamdani M; Hackam DG; Jain AK; Garg AX
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1544-51. PubMed ID: 20595693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune hemolytic anemia associated with trimethoprim-sulfamethoxazole use.
    Frieder J; Mouabbi JA; Zein R; Hadid T
    Am J Health Syst Pharm; 2017 Jun; 74(12):894-897. PubMed ID: 28596226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible voltage-dependent distal renal tubular acidosis in a patient receiving standard doses of trimethoprim-sulphamethoxazole.
    Lin SH; Kuo AA; Yu FC; Lin YF
    Nephrol Dial Transplant; 1997 May; 12(5):1031-3. PubMed ID: 9175064
    [No Abstract]   [Full Text] [Related]  

  • 37. Trimethoprim-induced exacerbation of hyperkalemia in a dog with hypoadrenocorticism.
    Rubin SI; Toolan L; Halperin ML
    J Vet Intern Med; 1998; 12(3):186-8. PubMed ID: 9595382
    [No Abstract]   [Full Text] [Related]  

  • 38. ACP Journal Club. Trimethoprim-sulfamethoxazole was linked to sudden death in older patients using spironolactone.
    Ananthakrishnan S
    Ann Intern Med; 2015 Jun; 162(12):JC13. PubMed ID: 26075778
    [No Abstract]   [Full Text] [Related]  

  • 39. Electrocardiographic changes after shoulder arthroplasty.
    Marinella MA
    Heart Lung; 2008; 37(5):390-3. PubMed ID: 18790340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperkalemia and high-dose trimethoprim/sulfamethoxazole.
    Hsu I; Wordell CJ
    Ann Pharmacother; 1995 Apr; 29(4):427-9. PubMed ID: 7633023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.